Showing the single result
Manufacturer: Galderma Active Substance(s) : POLYLACTIC…
Sculptra® and Galderma — FDA-Approved Collagen Biostimulator
Galderma is a global pure-play dermatology company operating across approximately 90 countries with one of the broadest injectable aesthetics portfolios in the category [5]. Its range spans botulinum toxins, hyaluronic acid fillers, and collagen biostimulators — with Sculptra® as its flagship PLLA product and the centerpiece of its regenerative aesthetics offering. The company’s clinical investment in PLLA biostimulation has continued since Sculptra®’s initial approval: a 2021 label update authorized immediate reconstitution as a validated alternative to the extended rest protocol [4], and in April 2023 the FDA approved a further indication expansion to fine lines and wrinkles in the cheek region [1][2][5]. Galderma’s Aesthetic Injector Network (GAIN) training platform supports practitioners globally in refining Sculptra® injection technique and treatment planning.
Sculptra® is FDA-approved and supplied as a lyophilized powder requiring reconstitution with sterile water prior to each use. Each vial contains 150 mg of PLLA-SCA particles within a matrix of carboxymethylcellulose and non-pyrogenic mannitol [2][3]. Unlike hyaluronic acid fillers, which displace tissue to produce immediate volume, Sculptra® functions as a collagen biostimulator: its PLLA microparticles initiate a controlled biological response that drives fibroblast activity and endogenous collagen synthesis over weeks to months [2][5]. The result is gradual, natural-looking volume restoration — a distinction that defines the biostimulator category and sets Sculptra® apart from conventional HA-based injectables.
The Sculptra® Galderma price is affected by supply chain and procurement logistics, and as a Sculptra® supplier, we at Medica Depot are proud to offer the best cost on the market.
Most Popular Sculptra® Products
Sculptra® (2 vials) contains 367.5 mg of lyophilized product (150 mg of PLLA-SCA microparticles plus excipients) and must be reconstituted per the manufacturer’s protocol before use [2][3]. The two-vial format supports a standard initial treatment session and is the format practitioners most commonly stock for multi-session facial rejuvenation programs.
The product is indicated for nasolabial fold correction, cheek wrinkles, and other facial wrinkles associated with volume loss, with each session building on the last as collagen synthesis progresses [1][2]. Practitioners managing ongoing treatment cycles can buy Sculptra® injections online via Medica Depot’s reorder workflow, with verified LOT numbers on every shipment and wholesale-account pricing available to licensed buyers.
Sculptra® does not include pre-filled or ready-to-use formats — the lyophilized powder format is by design, preserving microparticle suspension integrity until the point of reconstitution and injection [3].
Treatment Areas and Indications
Sculptra® has FDA approval for specific facial indications, as well as off-label applications that practitioners must clearly communicate to patients before proceeding.
Nasolabial fold correction is Sculptra®’s original and most extensively documented aesthetic indication, supported by clinical data from multi-session protocols addressing shallow-to-deep contour deficiencies [2]. The 2023 FDA approval expanded the cleared indication to include fine lines and wrinkles in the cheek region — a first for any PLLA biostimulator, supported by clinical trial data showing durable results at both 1 and 2 years following treatment [1][2]. These two indications represent the product’s core approved scope, with cheek wrinkles and other facial wrinkles associated with volume loss firmly within the authorized label.
Off-label applications extend Sculptra’s clinical reach beyond those approved indications. This is why clinicians buy Sculptra® more often, as it provides a wider range of treatment options.
- Sculptra® jawline and pre-masseteric placement is practiced off-label without FDA-approved indication status, which must be disclosed to patients.
- Sculptra® under-eye applications are advanced practice, but the periorbital area carries an elevated risk of nodules, as documented in the prescribing information — this should be treated as an advanced, high-caution application [3].
- Sculptra® for neck laxity is an emerging area where evidence remains limited compared with facial indications, and pre-treatment counseling should reflect this.
- Sculptra® butt lift procedures are practiced off-label by some clinicians for gluteal augmentation. However, this is not an FDA-approved indication, and practitioners must clearly communicate the distinct risk profile of high-volume body injection to every patient prior to treatment [3].
Administration — Reconstitution and Injection Protocol
What clinicians need to know before they buy Sculptra® online?
Per the FDA-reviewed product documentation, Sculptra® is placed in the deep dermis or subcutaneous layer, with supraperiosteal placement appropriate in selected anatomical sites [3]. Superficial injection is explicitly contraindicated — placement above the intended depth increases the risk of papules and visible surface irregularities [3].
Reconstitution requires 5-8 mL of sterile water for injection per vial [3]. Under the standard protocol, the suspension rests for at least two hours before use; under the 2021 label update, immediate reconstitution is a clinically validated alternative confirmed through a peer-reviewed study to be safe and effective [4]. An optional 1 mL of 2% lidocaine may be added immediately before injection for patient comfort [3].
A typical Sculptra® treatment course involves up to four sessions spaced approximately three to four weeks apart [1][3]. Practitioners should avoid overcorrecting in any single session — the product’s progressive mechanism means cumulative results only become apparent weeks after each treatment, and overtreatment in a single session can produce a disproportionate outcome as collagen continues to develop. Post-treatment, the recommended aftercare involves five minutes of massage, five times daily for five consecutive days, which helps ensure even product distribution and reduces the risk of nodules [3].
On two questions practitioners frequently relay from patients: Sculptra® injection-site discomfort, tenderness, and transient pain are commonly reported post-treatment experiences — the optional lidocaine admixture substantially reduces procedural discomfort [3]. As for how long Sculptra® takes to work, most patients observe early improvement at approximately three months, with continued collagen development through to around six months after the final session, and clinical evidence supports durability of results at the two-year mark [1].
At Medica Depot, you can find Sculptra® for sale at wholesale prices.
Why Practitioners Choose to buy Sculptra® online from Medica Depot?
Sculptra® earns its place in a practice formulary by doing something no HA filler can replicate: building structural volume from the patient’s own biology rather than occupying space beneath the skin. The progressive nature of the result — emerging weeks after treatment as new collagen forms — produces improvement that integrates with the patient’s anatomy rather than announcing itself at the treatment visit [1][5]. For patients seeking facial rejuvenation that reads as a natural change rather than a visible procedure, this distinction is both a clinical rationale and a commercial one.
Duration reinforces the proposition. Sculptra® results routinely persist for two years or more — substantially longer than most HA fillers and many competing biostimulators — which changes the economics of a practice’s injectable program [1]. Fewer maintenance visits, lower annualized product spend per patient, and a different kind of patient relationship follow from a product that works on a two-year timeline. Within a comprehensive treatment plan, Sculptra® addresses foundational volume decline in a way that complements, rather than competes with, neurotoxins that handle dynamic lines and HA fillers that manage surface correction.
Medica Depot offers an extensive catalog of biostimulators, and it is one of the best places where clinicians can buy Sculptra® wholesale. We offer exceptional logistics and a 14 day shipping guarantee, with affordable prices across a range of injectables.
Sculptra® vs Competing Biostimulators and Fillers
Here is a comprehensive comparison to go over, before you buy Sculptra® wholesale.
Sculptra® vs Radiesse®
Both are biostimulators but differ in their active substances and onset profiles. Sculptra® uses PLLA-SCA microparticles; Radiesse® uses calcium hydroxylapatite (CaHA) microspheres suspended in a CMC gel carrier. CaHA delivers an immediate volumizing effect at the time of injection alongside its biostimulatory action, whereas Sculptra® provides only gradual collagen induction with no same-session volume contribution [2][5]. Practitioners weighing onset timing against biostimulatory depth can buy Radiesse® through Medica Depot and assess which profile better fits their patient’s goals and timeline expectations.
Sculptra® vs ELLANSÉ™
ELLANSÉ™ uses polycaprolactone (PCL) microspheres in a CMC gel carrier, delivering immediate volume through the gel while stimulating collagen as the PCL degrades over time. Sculptra® offers no immediate volumizing effect — only the gradual PLLA-driven biostimulation that unfolds across the treatment series [2]. Practices whose patients require visible correction at the treatment visit alongside a biostimulatory component can buy ELLANSÉ™ through Medica Depot; those building protocols around a purely progressive biological result may find Sculptra® the more fitting choice.
Sculptra® vs HArmonyCA™
HArmonyCA™ combines CaHA with hyaluronic acid in a hybrid formulation, providing both immediate HA-based volume and sustained CaHA biostimulation in a single injection. Sculptra® does not deliver immediate volume, operating solely through progressive PLLA-driven collagen production. For patients requiring visible correction at the treatment visit alongside a biostimulatory component, HArmonyCA™ offers a different proposition. Clinicians may buy HArmonyCA™ or Sculptra® from Medica Depot to ensure authenticity.
Sculptra® vs JUVÉDERM®
The Sculptra® vs JUVÉDERM® comparison is a biostimulator-versus-filler distinction. JUVÉDERM® delivers immediate HA-based volume correction with enzymatic reversibility; Sculptra® produces no immediate change and cannot be dissolved. The trade-off: Sculptra®’s collagen-stimulated improvement typically lasts longer and is perceived as more naturally integrated. Practitioners may buy JUVÉDERM® for patients prioritizing reversibility or same-session results; those seeking a gradual, extended outcome suit Sculptra®.
Sculptra® vs RESTYLANE®
Like JUVÉDERM®, RESTYLANE® is an HA dermal filler that provides immediate correction with enzymatic reversibility — a fundamentally different clinical proposition from Sculptra®’s gradual, non-reversible mechanism [2]. In practice, the two serve complementary rather than competitive roles: HA fillers for patients requiring immediate surface correction; Sculptra® for longer-term foundational volume restoration that no HA product can sustain for comparable duration [1]. Clinics that run both categories can buy RESTYLANE® through Medica Depot alongside their Sculptra® supply.
Sculptra® vs BELOTERO®
BELOTERO® is an HA filler range designed for smooth integration in superficial tissue — particularly suited to fine lines and areas where a softer, less structured gel is indicated. Sculptra® cannot be placed superficially without increasing the risk of elevated nodules and operates in a different tissue plane entirely, addressing deeper volume loss rather than surface texture [3]. The two products are functionally complementary within a layered treatment approach: BELOTERO® managing superficial refinement, Sculptra® handling the foundational collagen-building layer beneath. Clinics can buy BELOTERO® from Medica Depot to run alongside Sculptra® within this tiered protocol.
Regulatory Status
Sculptra® received its first FDA approval on August 3, 2004, for correction of HIV-associated facial lipoatrophy. The indication expanded in 2009 to nasolabial fold correction and other facial wrinkles in immune-competent patients, and in April 2023 the FDA approved a further expansion to fine lines and wrinkles in the cheek region — the first PLLA biostimulator to hold this indication [1][2]. Sculptra® is currently available in more than 40 countries globally [5].
The PLLA composition is biocompatible and biodegradable — the same polymer class used in resorbable surgical sutures — and clinical follow-up data support durable results over 2 years of observation [1][2]. Results are long-lasting but not permanent: PLLA particles are metabolized over approximately 18 to 24 months, and the biostimulated collagen response diminishes over time [2][3]. Unlike HA fillers, Sculptra® cannot be enzymatically reversed, making accurate placement and conservative per-session dosing essential from the outset [3].
Sculptra® Safety Profile — Side Effects, Nodules, and Contraindications
Adverse events associated with Sculptra® are primarily localized and consistent with those expected from any deep injectable procedure. Common injection-site reactions — bruising, swelling, redness, tenderness, pain, bleeding, and transient lumps — are generally mild to moderate in severity and resolve within days to weeks of each session [3].
Sculptra® has more than two decades of global clinical and commercial use, and the adverse event profile documented across that experience is consistent with what the FDA-reviewed product documentation describes: primarily localized, technique-sensitive, and manageable with proper adherence to protocol [1][2][3].
As for Sculptra® nodule formation, it is a documented, technique-dependent risk. FDA-reviewed evidence consistently identifies inadequate dilution, excessively superficial injection depth, and failure to follow post-treatment massage as the primary contributing factors [3]. Proper reconstitution volume, correct injection depth, and adherence to the five-day aftercare massage protocol substantially reduce this risk. Nodules that do occur are typically palpable rather than visible, and many resolve without intervention; persistent cases may be managed with saline injection or drainage.
Regarding whether Sculptra® migrates, PLLA microparticles remain localized at the injection site and gradually degrade over 18 to 24 months [3]. Post-treatment surface irregularities are generally attributable to injection technique or non-compliance with aftercare rather than to product displacement.
Contraindications to Know Before You Order Sculptra®
These include known hypersensitivity to any component of the formulation, a history of keloid formation or susceptibility to hypertrophic scarring, and active skin infection or inflammation at the planned injection site [2][3]. When reconstituted with lidocaine, allergy to amide-type local anesthetics is an additional contraindication [3]. Use during pregnancy and breastfeeding has not been studied and should be deferred. Practitioners should review all warnings, precautions, and adverse events in the full prescribing information before use.
Medica Depot supplies Sculptra® at verified wholesale pricing for licensed aesthetic practitioners — with group-buy options, fast international shipping, and confirmed LOT numbers on every order. Purchase Sculptra® through verified online suppliers, or buy dermal fillers and buy biostimulators to consolidate your aesthetic injectable sourcing in one place.
FAQs
Who may prefer a gradual Sculptra® treatment approach?
A patient who understands the delayed timeline and accepts serial assessment may prefer it when collagen-mediated change fits the clinical goal.
Does PLLA provide lasting volume immediately?
No. Early fullness is mainly related to fluid and swelling. The intended effect develops later as collagen formation progresses.
Can one Sculptra® session be enough?
Possibly, but responses vary. US instructions allow a regimen of up to four sessions, and each additional session should follow reassessment. Clinics can still order Sculptra® wholesale, as use-cases extend beyond approved indications.
Does Sculptra® treat dynamic expression lines?
Sculptra® does not relax muscles. Dynamic lines may call for a neuromodulator or another approach after clinical evaluation.
What influences how long improvement remains visible?
The indication, baseline anatomy, completed regimen, individual collagen response, aging, health factors, and later procedures may all contribute.
Is gluteal treatment an approved use?
No. Gluteal injection is off-label in the United States and differs from approved facial use in anatomy, volume, evidence, and risk.
May Sculptra® and HA filler appear in one treatment plan?
They may address different goals, but timing and placement require individualized planning so safety, tissue response, and attribution of adverse events remain clear. Overall, Sculptra® can be combined with a number of aesthetic treatments. This is what we hear when clinics order Sculptra® online from Medica Depot, and what the broader relevant literature suggests.
What should a comparison between injectables include?
It should cover indication, material, onset, tissue plane, duration evidence, reversibility, expected reactions, serious risks, and practitioner training. Clinic managers and practitioners can read how this treatment compares against other competitors above, before they order Sculptra® online.
Disclaimer
The contents of this page are meant for licensed medical professionals. They serve informational purposes only and are not to be taken as medical advice.
Citations and Resources about Sculptra®
[1] Fabi S, Hamilton T, LaTowsky B, et al. Effectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles. Journal of Drugs in Dermatology. 2024. https://pubmed.ncbi.nlm.nih.gov/38206151/
[2] U.S. Food and Drug Administration. Sculptra – P030050/S039. FDA. 2023. https://www.fda.gov/medical-devices/recently-approved-devices/sculptra-p030050s039
[3] U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data for Sculptra. FDA. https://www.accessdata.fda.gov/cdrh_docs/pdf3/P030050S039B.pdf
[4] Palm M, Weinkle S, Cho Y, LaTowsky B, Prather H. A Randomized Study on PLLA Using Higher Dilution Volume and Immediate Use Following Reconstitution. Journal of Drugs in Dermatology. 2021. https://pubmed.ncbi.nlm.nih.gov/34232000/
[5] Galderma. Galderma receives FDA approval for Sculptra® for cheek wrinkles. Published April 26, 2023. https://www.galderma.com/news/galderma-receives-fda-approval-sculptrar-cheek-wrinkles-0
Written by the Medica Depot Editorial Staff
This content was prepared and reviewed under our editorial guidelines , which govern how we source, verify, and update clinical and product information. Every claim is checked against peer-reviewed research, manufacturer documentation, or regulatory guidance before publication.
Choosing the right products starts with confidence in their authenticity. At Medica Depot, we prioritize genuine branded products, reliable sourcing, and quality you can trust. Explore our standards and learn more about how we ensure product authenticity.